In a patient with resting tremor that improves with voluntary movement, facial rigidity, and shuffling gait, which imaging study can confirm the diagnosis?

MRI Brain Without Contrast is the Optimal Initial Imaging Study

For a patient presenting with classic Parkinsonian features (resting tremor improving with voluntary movement, facial rigidity, and shuffling gait), MRI of the brain without IV contrast is the optimal imaging modality to support the diagnosis. 1

Rationale for MRI as First-Line Imaging

MRI brain without contrast serves as the foundation for evaluating Parkinsonian syndromes because of its superior soft-tissue characterization and sensitivity to iron deposition compared to CT 1. While the diagnosis of Parkinson's disease remains primarily clinical, imaging plays an essential role in:

• Excluding alternative diagnoses such as structural lesions, vascular disease, or atypical Parkinsonism (MSA, PSP, CBD)
• Detecting patterns of regional atrophy characteristic of atypical Parkinsonian syndromes
• Identifying iron deposition patterns in the substantia nigra

Advanced MRI Techniques

Recent literature suggests that susceptibility-weighted imaging (SWI) can demonstrate the "swallow tail" sign—signal changes in the dorsolateral substantia nigra that may help diagnose PD, though sensitivity and specificity remain under investigation 1. Advanced MRI at 7-Tesla has shown promise in differentiating PD patients from healthy subjects by demonstrating increased susceptibility and thinning of the pars compacta 1.

When to Add Functional Imaging

I-123 Ioflupane SPECT/CT (DaTscan)

If the clinical diagnosis remains uncertain after MRI, I-123 ioflupane SPECT/CT is the most valuable functional imaging test 1. This study:

• Differentiates Parkinsonian syndromes from essential tremor and drug-induced tremor with high accuracy
• Demonstrates abnormality early in the disease course compared to anatomic imaging
• Shows decreased radiotracer uptake in the striatum (putamen to caudate nuclei pattern)
• A normal scan essentially excludes Parkinsonian syndromes 1

Critical limitation: DaTscan cannot distinguish between PD and atypical Parkinsonisms (MSA, PSP, CBD), as all show abnormal dopaminergic depletion 1.

Imaging Algorithm

1. Start with MRI brain without contrast in all patients with suspected Parkinsonism

   • Look for patterns of atrophy suggesting atypical Parkinsonism
   • Assess for structural lesions or vascular disease
   • Consider SWI sequences if available

2. Add I-123 ioflupane SPECT/CT if:

   • Clinical distinction between PD and essential tremor is unclear
   • Drug-induced Parkinsonism needs exclusion
   • Early confirmation of nigrostriatal dopaminergic loss is needed

3. Consider FDG-PET/CT only for distinguishing PSP from idiopathic PD (shows characteristic hypometabolism in medial frontal cortex, anterior cingulate, striatum, and midbrain in PSP) 1

What NOT to Order

• CT head: Limited soft-tissue characterization; only useful to exclude gross structural abnormalities 1
• Amyloid PET/CT: No role in Parkinsonian syndrome evaluation 1
• MR spectroscopy or fMRI: No supporting literature for initial evaluation 1

Common Pitfalls

Pitfall #1: Ordering functional imaging first without structural imaging. Always obtain MRI first to exclude mimics and identify atypical features.

Pitfall #2: Expecting imaging to definitively diagnose idiopathic PD. The diagnosis remains clinical; imaging supports it by excluding alternatives and confirming dopaminergic dysfunction.

Pitfall #3: Using DaTscan to distinguish between different Parkinsonian syndromes. It cannot differentiate PD from MSA, PSP, or CBD—all show abnormal patterns 1.